Learn More
- Professor of Physiology and Neuroscience, Professor of Neurology, Zilkha Neurogenetics Institute, Keck School of Medicine, USC
- Former Chair, and founder of Dept. of Neurology, Cedars-Sinai
- Clinical leader on the pivotal NINDS clinical trial leading to tPA approval
- Director, Stroke Preclinical Assessment Network (SPAN)
- 2019 William M. Feinberg Award for Excellence in Clinical Stroke, American Stroke Association
- Lead Principal Investigator on ZZ Biotech’s Phase 2 stroke trial, RHAPSODY and Phase 3 RHAPSODY 2
• Professor and Senior Associate Vice-Chair of Neurology at UC Los Angeles
• Director of the UCLA Comprehensive Stroke Center
• Served as Principal Investigator of the NIH-NINDS FAST-MAG trial, global Principal Investigator of the SWIFT PRIME trial, and held leadership positions in many other stroke studies
• Chair of the American Heart Association Stroke Council
• Associate Professor of Neurology, Neurosurgery, and Radiology, The Mount Sinai Hospital
• Associate Director of the Cerebrovascular Center and Director of the Endovascular Stroke Program at the Mount Sinai Health System
• Investigator in several multi-center stroke clinical trials
• Fellow and National Board Member of the Society for Vascular and Interventional Neurology
• Vice Chair of Research and Stroke Division Chief in the Department of Neurology, Wake Forest University
• Director of the Wake Forest Baptist Stroke Center
• Principal Investigator, Western North Carolina StrokeNet (Regional Coordinating Center)
• Director of the Division of Cerebrovascular Disease and Head of the Comprehensive Stroke Center at the University of Iowa Department of Neurology
• Principal Investigator, University of Iowa Regional Coordinating Center for StrokeNet
• Served on Stroke Council, American Stroke Association and Chair, Vascular Neurology Section, American Academy of Neurology